TrialCurrent pharmaceutical design2026

Mebendazole as an Adjunct Therapy with Mesalamine to Increase Efficacy and Maintenance Therapy for Ulcerative Colitis Patients: A Pilot Study.

Moein Eskandari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.